Abbott Laboratories (ABT) Stock Price & Analysis
Market: NYSE • Sector: Healthcare • Industry: Medical - Devices
Abbott Laboratories (ABT) Profile & Business Summary
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Key Information
| Ticker | ABT |
|---|---|
| Exchange | NYSE |
| Official Site | https://www.abbott.com |
Market Trend Overview for ABT
One model, two time views: what the market looks like right now, and where the larger trend is heading over time.
SRE (WhaleQuant Structural Regime Engine) SRE evaluates how price structure evolves across daily and weekly timeframes to define the prevailing market regime. Beyond identifying trends, consolidations, and exhaustion phases, it distinguishes between raw structural strength and deployable participation quality. The model dynamically adjusts for structural context and extension risk, assessing whether conditions are supportive, stretched, fragile, or structurally impaired. Its purpose is not to forecast precise price levels, but to determine whether risk deployment is aligned with underlying market structure.
Longer-Term Market Trend (Mid to Long Term)
Shows the bigger market trend, how strong it is, and where risks may start to build over the next few weeks or months. — Updated as of 2026-10-01 (ET)
As of 2026-10-01, ABT is showing signs of slowing down. Over the longer term, the trend remains bearish.
ABT last closed at 96.69. The price is about 2.2 ATR below its recent average price (101.50), and the market is currently in a trend that may be losing strength. Price at 96.69 is near minor support around 87.64. Momentum may slow, while minor resistance sits near 104.54. View Support & Resistance from Options
Short-term and long-term trends are aligned to the downside, keeping downside risk dominant.
Trend score: 45 out of 100. Overall alignment is unclear. The market is currently in a late-stage trend that may be losing strength. The longer-term trend is still negative, but short-term signals are not yet confirming it.
Price is stretched well below its recent average (about 2.2 ATR). Downside extension is elevated, and chasing weakness here carries a higher rebound risk.
There is no clear key risk boundary right now.
On 2026-09-01, trend conditions deteriorated, suggesting that moves in the prior direction became less dependable.
[2026-09-03] Price moved quickly and looked strong, but participation was limited.
Recent price action continues to trend lower in a relatively orderly manner, with no clear signs of structural stabilization yet emerging.
There was no clear sign of meaningful positions being carried into the overnight session.
The model does not deploy the setup because the current position looks stretched and more vulnerable to pullback or digestion.
The model does not deploy this setup because pullback risk is 57%, entry geometry is unfavorable at the current location, price is still close to a gamma transition zone, and recent price behavior has shown failed reversal memory. Predictability is 44%, agreement is 93%, and reversal risk is 26%.
NOTE: This next-day up/down probability forecast module is still being tested for accuracy. Please do not rely on it for investment decisions. The model does not account for black swan events or company-specific fundamental news, and its estimates are based solely on technical conditions, capital flow, and market sentiment. View forecast history
This estimate uses 1-minute price, volume, and VWAP data from the last 50 trading days, with turnover-based decay. The sample period is 2026-07-23 to 2026-10-01. The current price is 96.69, 9.80% below the estimated average cost of 107.20. An estimated 0.1% of recent positioning is below the current price, while 99.8% is above it. The peak-density price is 114.90. The largest concentrated cost region is 101.72 to 103.53 and contains 16.0% of the estimated distribution. The nearest region above the current price is 100.67 to 101.48.
Short Interest & Covering Risk for ABT
This analysis looks at overall short interest positioning, focusing on the broader setup rather than short-term noise.
Shows how likely a short squeeze may be under current market conditions.
Short Exposure Percentile
Short interest is relatively low, indicating limited pressure from short positions. (Historical percentile: 4%)
Structure Analysis
ABT Short positioning looks normal. Current days to cover is 2.6 trading days, meaning short positions would unwind somewhat slower than average. Short covering is likely to have a normal impact on price moves. Price is already trending lower (20D return -12.5%). The current configuration reflects active downside pressure rather than latent structural fragility.
Risk Summary
No clear bull trap characteristics detected. Recent price behavior remains broadly consistent with current positioning.This reading helps confirm that current price action remains structurally healthy and does not indicate elevated trap risk.
Why Price Reactions May Be Stronger?
Average trading volume is weakening, indicating contracting liquidity. Adaptive thresholds applied to liquidity weakness, near-high detection, and compression sensitivity. As a result, similar news or market events could lead to price moves about 1× larger than usual.
Note:
Short interest data is reported every two weeks by
FINRA.
The most recent snapshot is
2026-09-15 (ET).
Because this data updates slowly, it is not intended to predict short-term price moves. Instead, it helps describe longer-term market structure and where pressure may be building if prices begin to move.